19-33302101-TCGCCGCCGC-TCGCCGCCGCCGC
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2
The NM_004364.5(CEBPA):c.311_313dupGCG(p.Gly104dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000976 in 1,322,134 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000077 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )
Consequence
CEBPA
NM_004364.5 conservative_inframe_insertion
NM_004364.5 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.85
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_004364.5
BP6
Variant 19-33302101-T-TCGC is Benign according to our data. Variant chr19-33302101-T-TCGC is described in ClinVar as [Likely_benign]. Clinvar id is 408748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEBPA | NM_004364.5 | c.311_313dupGCG | p.Gly104dup | conservative_inframe_insertion | 1/1 | ENST00000498907.3 | NP_004355.2 | |
CEBPA | NM_001287424.2 | c.416_418dupGCG | p.Gly139dup | conservative_inframe_insertion | 1/1 | NP_001274353.1 | ||
CEBPA | NM_001287435.2 | c.269_271dupGCG | p.Gly90dup | conservative_inframe_insertion | 1/1 | NP_001274364.1 | ||
CEBPA | NM_001285829.2 | c.-47_-45dupGCG | 5_prime_UTR_variant | 1/1 | NP_001272758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEBPA | ENST00000498907.3 | c.311_313dupGCG | p.Gly104dup | conservative_inframe_insertion | 1/1 | 6 | NM_004364.5 | ENSP00000427514.1 |
Frequencies
GnomAD3 genomes AF: 0.0000769 AC: 11AN: 142988Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
142988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000400 AC: 22AN: 54968Hom.: 0 AF XY: 0.000433 AC XY: 14AN XY: 32314
GnomAD3 exomes
AF:
AC:
22
AN:
54968
Hom.:
AF XY:
AC XY:
14
AN XY:
32314
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000100 AC: 118AN: 1179146Hom.: 0 Cov.: 33 AF XY: 0.000114 AC XY: 65AN XY: 572104
GnomAD4 exome
AF:
AC:
118
AN:
1179146
Hom.:
Cov.:
33
AF XY:
AC XY:
65
AN XY:
572104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000769 AC: 11AN: 142988Hom.: 0 Cov.: 32 AF XY: 0.0000717 AC XY: 5AN XY: 69714
GnomAD4 genome
AF:
AC:
11
AN:
142988
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
69714
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Acute myeloid leukemia Pathogenic:1Benign:1
Likely pathogenic, flagged submission | clinical testing | Genomic Diagnostics Laboratory, National Institute of Medical Genomics | - | The variant was detected in bone marrow from patients, but it was not confirmed in the matched - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Dec 03, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at